Hikma Pharmaceuticals PLC (HIK.L)

GBp 1881.0

(-0.21%)

Operating Income Summary of Hikma Pharmaceuticals PLC

  • Hikma Pharmaceuticals PLC's latest annual operating income in 2023 was 367 Million USD , down -37.9% from previous year.
  • Hikma Pharmaceuticals PLC's latest quarterly operating income in 2024 Q2 was 351 Million USD , down 0.0% from previous quarter.
  • Hikma Pharmaceuticals PLC reported an annual operating income of 591 Million USD in 2022, down -6.78% from previous year.
  • Hikma Pharmaceuticals PLC reported an annual operating income of 634 Million USD in 2021, up 17.41% from previous year.
  • Hikma Pharmaceuticals PLC reported a quarterly operating income of 310 Million USD for 2023 Q4, down 0.0% from previous quarter.
  • Hikma Pharmaceuticals PLC reported a quarterly operating income of 309 Million USD for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of Hikma Pharmaceuticals PLC (2023 - 2002)

Historical Annual Operating Income of Hikma Pharmaceuticals PLC (2023 - 2002)

Year Operating Income Operating Income Growth
2023 367 Million USD -37.9%
2022 591 Million USD -6.78%
2021 634 Million USD 17.41%
2020 540 Million USD 11.11%
2019 486 Million USD 13.55%
2018 428 Million USD 27.38%
2017 336 Million USD -16.21%
2016 401 Million USD 2.04%
2015 393 Million USD -6.21%
2014 419 Million USD 6.08%
2013 395 Million USD 136.85%
2012 166.77 Million USD 40.51%
2011 118.68 Million USD -12.14%
2010 135.09 Million USD 25.91%
2009 107.29 Million USD 32.98%
2008 80.68 Million USD -12.68%
2007 92.39 Million USD 22.79%
2006 75.24 Million USD 8.73%
2005 69.2 Million USD 10.34%
2004 62.72 Million USD 102.4%
2003 30.99 Million USD 37.97%
2002 22.46 Million USD 0.0%

Peer Operating Income Comparison of Hikma Pharmaceuticals PLC

Name Operating Income Operating Income Difference